Clinical Trial Update: Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating frontline therapy with blinatumomab, inotuzumab ozogamicin, and chemotherapy for B-cell acute lymphoblastic leukemia and B-cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Lymphoblastic Lymphoma

Drugs mentioned

• Blinatumomab (blinatumomab)
• Combination chemotherapy
• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Status: RECRUITING